StockNews.com Begins Coverage on Global Cord Blood (NYSE:CO)

Analysts at StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO) in a research report issued to clients and investors on Wednesday. The brokerage set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Stock Performance

Shares of Global Cord Blood stock opened at $0.95 on Wednesday. The stock has a 50 day moving average of $0.91 and a 200 day moving average of $1.13. The firm has a market capitalization of $115.47 million, a price-to-earnings ratio of 1.48 and a beta of 0.16. Global Cord Blood has a fifty-two week low of $2.03 and a fifty-two week high of $5.50.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.